FERRARI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.079
EU - Europa 7.001
AS - Asia 4.110
SA - Sud America 649
AF - Africa 95
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 9
Totale 23.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.938
GB - Regno Unito 1.996
IT - Italia 1.848
CN - Cina 1.455
SG - Singapore 1.332
DE - Germania 872
SE - Svezia 625
BR - Brasile 548
HK - Hong Kong 442
FR - Francia 335
RU - Federazione Russa 286
VN - Vietnam 256
UA - Ucraina 245
PL - Polonia 194
FI - Finlandia 172
TR - Turchia 170
KR - Corea 113
IN - India 93
BG - Bulgaria 92
CA - Canada 84
NL - Olanda 66
ID - Indonesia 49
JP - Giappone 49
BE - Belgio 45
ZA - Sudafrica 42
MX - Messico 37
IE - Irlanda 36
AR - Argentina 34
CH - Svizzera 33
ES - Italia 32
LT - Lituania 31
BD - Bangladesh 29
AT - Austria 25
IQ - Iraq 21
CZ - Repubblica Ceca 14
PK - Pakistan 14
PY - Paraguay 13
CL - Cile 12
EC - Ecuador 12
MA - Marocco 12
IR - Iran 11
PT - Portogallo 11
DK - Danimarca 10
EG - Egitto 10
MY - Malesia 10
AE - Emirati Arabi Uniti 9
UZ - Uzbekistan 9
AZ - Azerbaigian 8
VE - Venezuela 8
CO - Colombia 7
EU - Europa 7
HU - Ungheria 7
KE - Kenya 7
PE - Perù 7
AU - Australia 5
SA - Arabia Saudita 5
TN - Tunisia 5
UY - Uruguay 5
AL - Albania 4
BH - Bahrain 4
ET - Etiopia 4
GR - Grecia 4
HN - Honduras 4
JO - Giordania 4
NZ - Nuova Zelanda 4
RO - Romania 4
TZ - Tanzania 4
AM - Armenia 3
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GD - Grenada 3
KZ - Kazakistan 3
SN - Senegal 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
EE - Estonia 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PH - Filippine 2
RS - Serbia 2
CR - Costa Rica 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
GL - Groenlandia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MM - Myanmar 1
Totale 23.944
Salva come PNG Salva come JPEG
Città #
Southend 1.466
Fairfield 1.294
Ashburn 1.124
Santa Clara 1.078
Woodbridge 889
Singapore 790
Chandler 753
Houston 599
Seattle 525
Ann Arbor 512
Jacksonville 466
Dearborn 458
Cambridge 454
Wilmington 444
Hong Kong 439
Hefei 392
Frankfurt am Main 375
Nyköping 363
Modena 270
Beijing 252
London 230
New York 164
Los Angeles 161
Kraków 145
Chicago 107
Seoul 101
Princeton 98
Sofia 92
Izmir 91
Munich 89
San Diego 89
Eugene 87
Milan 87
Council Bluffs 85
Ho Chi Minh City 85
Shanghai 84
Moscow 82
Fremont 76
Helsinki 72
Redwood City 67
The Dalles 61
São Paulo 60
Rome 56
Boardman 55
Bologna 49
Hanoi 49
Buffalo 47
Bremen 46
Brussels 40
Warsaw 40
Salt Lake City 38
Dublin 36
Tokyo 36
Des Moines 35
Guangzhou 32
Brooklyn 31
Grafing 30
Jakarta 30
Naples 30
Verona 29
Falls Church 28
Orem 28
Dallas 27
Denver 27
Ottawa 27
Turku 26
Stockholm 25
Phoenix 24
Columbus 23
Parma 23
Norwalk 22
San Jose 22
Elk Grove Village 21
Belo Horizonte 20
Cape Town 20
Montreal 20
Tampa 19
Atlanta 18
Poplar 18
Chennai 17
Paris 17
Amsterdam 16
Dong Ket 16
Marseille 16
Milwaukee 16
Florence 15
San Francisco 15
Toronto 15
Jinan 14
Nanjing 14
San Gimignano 14
Johannesburg 13
Kunming 13
Manchester 13
Mexico City 13
Pavia 13
Reggio Emilia 13
Brno 12
Da Nang 12
Lancaster 12
Totale 16.602
Salva come PNG Salva come JPEG
Nome #
STRUTTURA DEL CRISTALLO DEL COMPLESSO DI TIMIDILATO SINTETASI (TS) CON UN LIGANDO 771
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 408
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 404
Metodo per la funzionalizzazione sito specifica di molecole proteiche 401
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase 380
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 375
Internalization and stability of a thymidylate synthase peptide inhibitor in ovarian cancer cells 372
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 369
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections 364
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 360
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections 355
Biochemistry: Anchors away 350
2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes 349
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 344
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 342
Improving specificity vs bacterial thymidylate synthases through N-dansyl modulation of didansyltyrosine 340
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance 329
Antibacterial agent discovery using thymidylate synthase biolibrary screening 324
Constrained dansyl derivatives reveal bacterial specificity of highly conserved Thymidylate Synthases A 320
2′-Deoxyuridine 5′-Monophosphate Substrate Displacement in Thymidylate Synthase through 6-Hydroxy-2H-naphtho[1,8-bc]furan-2-one Derivatives 319
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 317
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 317
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs 315
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment 309
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescence resonance energy transfer 305
NUOVE MOLECOLE, PER USO COME AGENTI ANTITUMORALI 305
Crystal Structure of histidine-tagged human thymidylate synthase 302
Allosteric Inhibition of human Thymidylate Synthase. 297
Structure-Based Selectivity Optimization of Piperidine–Pteridine Derivatives as Potent Leishmania Pteridine Reductase Inhibitors 296
Current and Future Chemotherapy for Chagas Disease 296
ANTICANCER DRUGS 285
Crystal Structure of human thymidylate synthase bound to a peptide inhibitor 283
“A step further in the discovery of phthalein derivatives as Thymidylate Synthase inhibitors” 283
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding 283
A proteomic approach to investigate the mechanism of action of anticancer peptides 281
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 281
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To InhibitTrypanosoma bruceiPteridine Reductase in Support of Early-Stage Drug Discovery 281
Maxwell A: F1000Prime Recommendation of Evaluation [Neres J et al., ACS Chem Biol 2014]. In F1000Prime, 09 Jan 2015; DOI: 10.3410/f.725248139.793502885. F1000Prime.com/725248139#eval793502885 279
Thymidylate synthase structure, function and implication in drug discovery 277
Hotspots in an obligate homodimeric anticancer target. structural and functional effects of interfacial mutations in human thymidylate synthase 277
Alternative strategies in medicinal chemistry to face drug resistance in anticancer therapy. 274
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells 274
Homodimeric Enzymes as Drug Targets 269
Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de]isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors 268
Development of flavonoids derivatives as leads against Leishmaniasis and Trypanosomiasis-invited lecture 268
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 265
Biochemical effects of riluzole on Leishmania parasites 265
Protein-protein interaction inhibitors: case studies on Small Molecules and Natural Compounds. 263
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent 259
Update on antifolate drugs targets 257
Zing meeting on Medicinal Chemistry 2012-Lanzarote-invitated lecture 254
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 253
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 252
Target-based approaches for the discovery of new antimycobacterial drugs 250
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 248
Targeting the trypanosomatidic enzymes pteridine reductase and dihydrofolate reductase. 247
QUINOXALINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS 247
Inhibitor of Ovarian Cancer Cells growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 246
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case 244
Identification of the binding modes of N-phenylphthalimides inhibiting bacterial thymidylate synthase through X-ray crystallography screening 244
Dal Ligand based design di inibitori della Timidilato Sintasi all'Analisi Comparativa dei Complessi Enzima-Inibitore 235
Intrinsic Fluorescence of the Active and the Inactive Functional Forms of Human Thymidylate Synthase 231
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 221
Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: evaluation of in vitro anti-cancer and anti-folate activities 220
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 219
COMPOSTI AD ATTIVITÀ ANTIPARASSITARIA 219
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 217
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 216
Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase 213
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 207
The structure of Cryptococcus neoformans thymidylate synthase suggests strategies for using target dynamics for species-specific inhibition 202
Anti-Parasitic drugsDiscovery of potent pteridine reductase inhibitors to guide antiparasite drug development. 196
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 195
Interfering with Human Thymidylate Synthase Dimerization against ovarian human carcinoma 191
Hits and Lead Discovery in the Identification of New Drugs against the Trypanosomatidic Infections 191
Congress on - Medicinal Chemistry in parasitology: new avenues in drug discovery-organised in Modena in 2007. 188
Interfering with Human Thymidylate Synthase Dimerization anti peptide design in the search of anticancer agents against ovarian human carcinoma 186
Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents 183
Ovarian Cancer Drug Resistance 177
Compounds having antiparasitic activity 176
Rapid-Throughput Technologies Applied to the Discovery of New Hits against Thymidylate synthase Enzymes 174
Inhibitor Specificity via Protein Dynamics. Insights from the Design of Antibacterial Agents Targeted Against Thymidylate Synthase 172
The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism 169
From ligand-based design to Hit validation of new thymidylate synthase inhibitors 148
Medicinal chemistry in parasitology 144
International Congress.Drug resistance in ovarian cancer:bomarkers andtreatments. 140
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 136
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 128
Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme family 124
Laboratory of reference for trypanosomatidic infections -In-Vitro-and-In-Vivo-Screenings-of-New-Antiparasitic-Compounds-State-of-the-art-and-New-Developments-COST B22 119
European COST B22 Lab for antiparasitic drug screening (http://www.icp.ucl.ac.be/cost/costB22/ screening_survey.pdf )-2008-2012. 112
Totale 24.241
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.796 0 0 0 0 0 196 237 314 156 530 240 123
2021/20222.086 92 189 184 103 81 213 98 140 227 134 404 221
2022/20232.254 243 282 162 226 220 309 52 212 236 50 134 128
2023/20241.800 54 92 114 128 608 184 95 153 69 38 109 156
2024/20254.190 191 60 134 274 817 538 325 230 401 162 474 584
2025/20263.997 456 309 563 906 1.222 541 0 0 0 0 0 0
Totale 24.241